The IDSA guidelines suggest that clinicians should start antiviral treatment as soon as possible for adults and children with documented or suspected influenza, irrespective of influenza vaccination history, who meet any of these criteria:
Individuals of any age who are hospitalized with influenza, regardless of illness duration prior to hospitalization
Outpatients of any age with severe or progressive illness, regardless of illness duration
Outpatients who are at high risk for complications due to influenza, including those with chronic medical conditions and immunocompromised patients
Children younger than 2 years and adults aged 65 years and older
Pregnant women and those within 2 weeks postpartum
The IDSA states that clinicians can consider antiviral treatment for adults and children with documented or suspected influenza who are not at high risk for influenza complications, irrespective of influenza vaccination history, who meet any of these criteria:
Outpatients with illness onset ≤ 2 days before presentation
Symptomatic outpatients who are household contacts of persons who are at high risk of developing complications from influenza, particularly those who are severely immunocompromised
Symptomatic healthcare providers who care for patients who are at high risk of developing complications from influenza, particularly those who are severely immunocompromised
This Fast Five Quiz was excerpted and adapted from the Medscape Drugs & Diseases article Influenza.
Medscape © 2020 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Michael Stuart Bronze. Fast Five Quiz: Key Aspects of Influenza - Medscape - Mar 31, 2020.